Skip to main content

Advertisement

Table 2 Morphological, biochemical, and symptomatic response in patients

From: Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas

Response criteria Response (N)
Morphological response (N = 25)
 Partial remission 7 (28%)
 Stable disease 14 (56%)
 Progressive disease 4 (16%)
Biochemical response (CgA) (N = 25)
 < 25% reduction 12 (48%)
 25–50% reduction 4 (16%)
 > 50% reduction 7 (28%)
 Increase in CgA 2 (8%)
Symptomatic response (anti-hypertensive drugs) (N = 14)
 Reduction of anti-HTN drugs 6 (43%)
 No change 8 (58%)